CRISPR/Cas9 technology generated a G to T change resulting in an arginine to leucine substitution at amino acid 161 (p.R161L) in exon 3. This is the first patient mutation found in a family with neuroendocrine cell hyperplasia of infancy. (J:323100)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count